Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2004 April;70(4) > Minerva Anestesiologica 2004 April;70(4):181-8

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

INTENSIVE CARE  SMART 2004 - Milan, May 12-14, 2004 Freefree

Minerva Anestesiologica 2004 April;70(4):181-8

Copyright © 2004 EDIZIONI MINERVA MEDICA

language: English

What can be done about acute renal failure?

Kellum J. A.

The CRISMA Laboratory (Clinical Research, Investigation and Systems Modeling of Acute illness), Department of Critical Care Medicine, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania, USA


PDF


Acute renal failure (ARF) complicates the clinical course of as many as 5% of all hospitalized patients with the critically ill and injured disproportionably at risk. Considerable effort has been expended to develop techniques to prevent ARF or to facilitate its resolution. However, to date, studies have failed to demonstrate that drugs can prevent onset or deterioration of renal function in the critically ill, and some studies have even suggested harm. Recent data suggest that NAC can reduce the incidence of ARF secondary to radio-contrast agents and improved techniques for RRT and, perhaps, new drugs aimed at improving cellular repair, will improve outcome from ARF in the future.

top of page